Medical AI Alliance
← Company Index
Healthcare InfrastructureKOSDAQ 1238401 approvals1 trials

NUON CO., LTD.

Official website

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

As of 2026-10-11, NUON CO., LTD. has 1 Korean MFDS device approval, 18 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2010 and listed on KOSDAQ in 2010, Nuon is a health functional food and household product company. It manufactures and sells individually recognized functional ingredients such as the fat-reduction ingredient Cissus, joint-health ingredients Gwanjeollyeok and Gwanjeol Plus gajac extract, the immune-boosting French Immune Echinacea, and the memory-improving Dr. Esther, along with household and cosmetic products under its Sallimbaekseo brand. 2025 revenue was led by Sallimbaekseo household products at 51.8%, Cissus at 24.6%, other merchandise sales (including Magic Kid) at 13.6%, and French Immune Echinacea at 4.9%, while its special-purpose machinery (vacuum deposition equipment) segment discontinued operations on December 5, 2025.

Products & technology

  • Cissus (Pil/Hyu/Su/Sports Burning Water)individually recognized fat-reduction functional food ingredient
  • Gwanjeollyeokindividually recognized joint/cartilage health ingredient (Boswellia extract)
  • Gwanjeol Plus gajac extractindividually recognized joint/cartilage health ingredient
  • Dr. Esther (Hyeonsam Plus Up)individually recognized memory-improvement ingredient
  • French Immune Echinaceaindividually recognized immune-boosting ingredient
  • Diglomera (Diglofit)individually recognized fat-reduction ingredient
  • Magic Kidchildren's height growth support product
  • Sallimbaekseohousehold, hair, body, and cosmetic products brand

Regulatory approvals

data.go.kr

1 Korean MFDS device approvals · 2017

  • MFDSGraft/prosthesis, biomaterialRevoked2017-03-20
    Product approval · Class 4제허 17-199 호

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2014 (Phase 2b 1)

  • Phase 2bDS-14042014-10-23

    1 trial site

R&D and key agreements

Source: DART corporate disclosure

개별인정형 기능성 원료 개발 · 체지방감소·관절건강·면역증진·기억력개선 등 · 지속(2018.12 시서스추출물 최초 허가 이후 확대) · In-house R&D center's material research and regulatory teams obtain MFDS individually recognized ingredient approvals through animal and human clinical studies

Key disclosures

KRX KIND via OpenDART
Show 3 more events

Publications

PubMed · affiliation-matched
Show 8 more publications

Patents

KIPRIS · applicant-matched
Show 23 more patents

AI reads

MAA server logs · IP-verified
63
Times AI engines pulled NUON CO., LTD.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

63
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

0
live 0
Last 7 days
49
live 0
Last 30 days
63
live 0
All time
  • OpenAIOAI-SearchBot45
  • GoogleGoogleOther13
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 2, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for NUON CO., LTD. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsHealthcare Infrastructure

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HANS BIOMED CORPORATION1 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

BioPlus Co., Ltd1 shared

Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.

BASKHANBIOPharma Inc.1 shared

Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

BIOBIJOU Co., Ltd.1 shared

KOSDAQ-listed aesthetics exporter behind HA skin booster CANDOLOV SERUM and filler brands COLENA and CANDORLOV.

Daehan Nupharm Co.,Ltd.1 shared

KOSDAQ-listed pharmaceutical company producing a diverse, low-volume portfolio of metabolic disease drugs, wellness injections, and veterinary medicines.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

PharmaResearch Co., Ltd.1 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

Humedix Co., Ltd.1 shared

KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.

Chong Kun Dang Pharmaceutical Corp.1 shared

Spun off and listed in 2013, Chong Kun Dang out-licensed its HDAC6 inhibitor CKD-510 to Novartis in a deal worth about KRW 1.7 trillion.

BNC KOREA, Inc.1 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition